Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News AGNC Investment Corporation AGNC

Alternate Symbol(s):  AGNCN | AGNCM | AGNCO | AGNCP | AGNCL | AGNCZ

AGNC Investment Corp. provides private capital to housing market in the United States. The company invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. It qualifies as a real estate investment... see more

Bullboard Posts (NDAQ:AGNC)

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
LeaMiles - April 13, 2023

$AGN.v up 30% today

$AGN.v up 30% today   They announced  Dr. David L. Brody has  been appointed an consultant.  Brody, a board...
stockpatrol - March 3, 2023

Progress from AGN DMT clinical stroke research program

Algernon Pharmaceuticals announces that they’ve initiated their DMT clinical stroke research program with their Phase 1 study in the...
biggonads - November 17, 2022

AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinic

AGN.c CEO Chris Moreau discussing Phase 2 of the Yale clinical trial for DMT.    https://www.youtube.com/watch?app...
stockpatrol - November 2, 2022

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
LeaMiles - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
LeaMiles - June 3, 2022